Hostname: page-component-84b7d79bbc-tsvsl Total loading time: 0 Render date: 2024-07-30T03:42:36.875Z Has data issue: false hasContentIssue false
  • English
  • Français

Oral delivery of novel therapeutics: development of a fowl adenovirus vector expressing chicken IL-2 and MGF

Published online by Cambridge University Press:  18 September 2007

J.W. Lowenthal ,
M.A. Johnson ,
S.G. Tyack ,
L.S. Hilton  and
A.G.D. Bean
J.W. Lowenthal*
Affiliation:
CSIRO Livestock Industries, Private Bag 24, Geelong 3220, Australia
M.A. Johnson
Affiliation:
CSIRO Livestock Industries, Private Bag 24, Geelong 3220, Australia
S.G. Tyack
Affiliation:
CSIRO Livestock Industries, Private Bag 24, Geelong 3220, Australia
L.S. Hilton
Affiliation:
CSIRO Livestock Industries, Private Bag 24, Geelong 3220, Australia
A.G.D. Bean
Affiliation:
CSIRO Livestock Industries, Private Bag 24, Geelong 3220, Australia
*
*Corresponding author: John.Lowenthal@CSIRO.au
Get access

Abstract

Delivery methods for commercial scale applications must be simple, inexpensive and cost-effective. The use of live vectors such as fowl adenoviruses (FAV) has previously been proven successful for the effective oral delivery of chicken interferon gamma to broilers under commercial growing conditions. FAV can be delivered via food or water or can be used as a spray. The ability of cytokines to modulate immune responses to vaccines and their therapeutic and growth promoting capability makes them an important component in future health management strategies for poultry. In this report, we describe the development of recombinant FAV vectors expressing chicken interleukin-2 (ChIL-2) and chicken myelomonocytic growth factor(cMGF). The ChIL-2 and cMGF genes were cloned into the right hand terminal region of FAV serotype 8, under the control of the adenovirus major late promoter. The in vitro biological activity of FAV-ChIL-2 and FAV-cMGF was comparable to that of the corresponding recombinant proteins expressed in prokaryotic (E. coli) and eukaryotic (COS cell) systems. These constructs may be particularly useful as therapeutics formucosal infections.

Keywords

cytokinesadenovirustherapeuticspoultryoral deliveryviral vectorsinterleukin-2
Type
Reviews
Information
World's Poultry Science Journal , Volume 61 , Issue 1 , March 2005 , pp. 87 - 94
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Babiuk, L.A., Sordillo, L.M., Campos, M., Hughes, H.P., Rossi Campos, A. and Harland, R. (1991) Application of interferons in the control of infectious diseases of cattle. Journal Diary Science 74: 4385–4398.Google Scholar
Blecha, F. (1991) Cytokines: applications in domestic food animals. Journal Diary Science 74: 328–339.CrossRefGoogle ScholarPubMed
Braciak, T.A., Mittal, S.K., Graham, F.L., Richards, C.D. and Gauldie, J. (1993) Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes. An approach to investigate in vivo cytokine function. Journal Immunology 151: 5145–5153.Google Scholar
Cheever, M.A., Thompson, J.A., Kern, D.E. and Greenberg, P.D. (1985) Interleukin-2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth. Journal Immunology 134: 3895–3900.CrossRefGoogle ScholarPubMed
Choi, K.D. and Lillehoj, H.S. (2000) Role of chicken IL-2 on gammadelta T-cells and Eimeria acervulina-induced changes in intestinal IL-2 mRNA expression and gammadelta T-cells. Veterinary Immunology and Immunopathology 73: 309–321.CrossRefGoogle ScholarPubMed
Condos, R., Rom, W.N. and Schluger, N.W. (1997) Treatment of multi-drug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 349: 1513–1515.Google Scholar
Cummins, J.M., Mock, R.E., Shive, B.W., Krakowka, S., Richards, A.B. and Hutcheson, D.P. (1995) Oral treatment of transmissible gastroenteritis with natural human interferon alpha: a field study. Veterinary Immunology Immunopathology 45: 355–360.Google Scholar
Donohue, J.H. and Rosenberg, S.A. (1983) The fate of interleukin-2 after in vivo administration. Journal Immunology 130: 2203–2208.CrossRefGoogle ScholarPubMed
Heath, A.W. and Playfair, J.H.L. (1992) Cytokines as immunological adjuvants. Vaccine 10: 427–434.Google Scholar
Hilton, L.S., Bean, A.D.G., Kimpton, W.G. and Lowenthal, J.W. (2002) Chicken interleukin-2 directly stimulates activation and proliferation of T cells in vivo. Journal Interferon Cytokine Research 22: 755–763.Google Scholar
Honda, Y., Waithaka, M., Taracha, E.L., Duchateau, L., Musoke, A.J. and Mckeever, D.J. (1998) Delivery of the Theileria parva p67 antigen to cattle using recombinant vaccinia virus: IL-2 enhances protection. Vaccine 16: 1276–1282.CrossRefGoogle ScholarPubMed
Joffret, M.L., Morgeaux, S., Laclerc, C., Oth, D., Zanetti, C., Sureau, P. and Perrin, P. (1990) Enhancement of interleukin-2 activity by liposomes. Vaccine 8: 385–389.Google Scholar
Johnson, M.A., Pooley, C. and Lowenthal, J.W. (2000) Delivery of avian cytokines by adenovirus vectors. Developmental Comparative Immunology 24: 343–354.CrossRefGoogle ScholarPubMed
Kaplan, D.R. (1994) Delivery of interleukin 2 for immunotherapy. Journal Chromatography Biomedical Applications 662: 315–323.Google Scholar
Karaca, K., Sharma, J.M., Winslow, B.J., Junker, D.E., Reddy, S., Cochran, M. and Mcmillen, J. (1998) Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16: 1496–1503.Google Scholar
Kehrli, M.E., Cullor, J.S. and Nickerson, S.C. (1991) Immunobiology of hematopoietic colony-stimulating factors: potential application to disease prevention in the bovine. Journal Diary Science 74: 4399–4412.Google Scholar
Kurilla, M.G., Swaminathan, S., Welsh, R.M., Kieff, E. and Brutkiewicz, R.R. (1993) Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. Journal Virology 67: 7623–7628.CrossRefGoogle ScholarPubMed
Knauf, M.J., Bell, D.P., Hirtzer, P., Luo, Z.P., Young, J.D. and Katre, N.V. (1988) Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. Journal Biological Chemistry 263: 15064–15070.Google Scholar
Leutz, A., Damm, K., Sterneck, E., Kowenz, E., Ness, S., Frank, R., Gausepohl, H., Pan, Y.C.E., Smart, J., Hayman, M. and Graf, T. (1989) Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationships to interleukin 6 and granulocyte colony stimulating factor. EMBO Journal 8: 175–181.CrossRefGoogle ScholarPubMed
Lowenthal, J.W., Connick, T.E., Mcwaters, P.G. and York, J.J. (1994) Development of T cell immune responsiveness in the chicken. Immunology Cell Biology 72: 115–122.CrossRefGoogle ScholarPubMed
Lowenthal, J.W., York, J.J., O'Neil, T.E., Rhodes, S., Prowse, S.J., Strom, A.D.G. and Digby, M.R. (1997) In vivo effects of chicken interferon gamma during infection with Eimeria. Journal Interferon Cytokine Research 17: 551–558.CrossRefGoogle ScholarPubMed
Lowenthal, J.W., Lambrecht, B., Van Den Berg, T.P., Andrew, M.E., Strom, A.D. and Bean, A.G. (2000) Avian cytokines – the natural approach to therapeutics. Developmental Comparative Immunology 24: 355–365.CrossRefGoogle ScholarPubMed
Marcus, P.I., Van Der Heide, L. and Sekellick, M.J. (1999) Chicken interferon action and avian viruses. I. Oral administration of interferon-alpha ameliorates Newcastle disease. Journal Interferon Cytokine Research 19: 881–885.CrossRefGoogle ScholarPubMed
Min, W., Lillehoj, H.S., Burnside, J., Weining, K.C., Staeheli, P. and Zhu, J.J. (2001) Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma TGF-beta4 and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine 20: 267–274.CrossRefGoogle ScholarPubMed
Minami, Y., Kono, T., Miyazaki, T. and Taniguchi, T. (1993) The IL-2 receptor complex: its structure, function, and target genes. Annual Review Immunology 11: 245–268.CrossRefGoogle ScholarPubMed
Miyamoto, T., Min, W. and Lillehoj, H.S. (2002) Kinetics of interleukin-2 production in chickens infected with Eimeria tenella. Comparative Immunolology Microbiology Infectious Disease 25: 149–158.CrossRefGoogle ScholarPubMed
Myers, T.J., Lillehoj, H.S. and Fetterer, R.H. (1992) Partial purification and characterization of chicken interleukin-2. Veterinary Immunology and Immunopathology 34: 97–114.Google Scholar
Ramshaw, I., Ruby, J., Ramsay, A., Ada, G. and Karupiah, G. (1992) Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo. Immunological Reviews 127: 157–182.Google Scholar
Rautenschlein, S., Sharma, J.M., Winslow, B.J., Mcmillen, J., Junker, D. and Cochran, M. (1999) Embryo vaccination of turkeys against Newcastle disease infection with recombinant fowlpox virus constructs containing interferons as adjuvants. Vaccine 18: 426–433.Google Scholar
Russell, W.C. (2000) Update on adenovirus and its vectors. Journal General Virology 81: 2573–2604.CrossRefGoogle ScholarPubMed
Schnetzler, M., Oommen, A., Nowak, J.S. and Franklin, R.M. (1983) Characterization of chicken T cell growth factor. European Journal Immunology 13: 560–566.CrossRefGoogle ScholarPubMed
Sheppard, M., Werner, W., Tsatas, E., Mccoy, R., Prowse, S. and Johnson, M. (1998) Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Archives Virology 143: 915–930.Google Scholar
Sundick, R.S. And Gill-Dixon, C. (1997) A cloned chicken lymphokine homologous to both mammalian IL-2 and IL-15. Journal Immunology 159: 720–725.Google Scholar
Tovey, M.G. and Maury, C. (1999) Oromucosal interferon therapy: marked antiviral and antitumor activity. Journal Interferon Cytokine Research 19: 145–155.Google Scholar
York, J.J., Strom, A.D.G., Connick, T.E., Mcwaters, P.G., Boyle, D.B. and Lowenthal, J.W. (1996) In vivo effects of chicken myelomonocytic growth factor: Delivery via a viral vector. Journal Immunology 156: 2991–2997.CrossRefGoogle Scholar